Canaccord cuts target for Orthofix Medical stock from USD 18.00 to USD 13.00
Published on 10/08/2026 at 13:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Orthofix Medical stock (ISIN US68752M1080) was trading at EUR 8.25 at Lang & Schwarz on October 8, 2026 at 1:43 p.m. CEST. Canaccord Genuity cut its price target from USD 18.00 to USD 13.00 on October 8, 2026, according to Webull.
Target cut resets the benchmark
The revised target places the analyst benchmark USD 4.75 below its former level. Canaccord Genuity maintained a Buy rating while lowering the target to USD 13.00, making the valuation reference more cautious even as the recommendation remained positive.
The change arrives as Orthofix trades near the lower end of its USD 8.50 to USD 16.99 52-week range. The range leaves USD 4.75 between the current primary-market reference of USD 8.50 and the Canaccord target, but the comparison uses different currencies from the Lang & Schwarz quote and is not a euro return calculation.
What does the target cut mean?
The main signal is a lower analyst hurdle rather than a change in the company identity or listing. Investing.com reported on September 15, 2026 that Stifel maintained a Buy rating and a USD 13.00 target. Two analyst houses therefore cited the same USD 13.00 level while Canaccord reduced its target from USD 18.00.
Three dated signals for OFIX
On September 15, 2026, Stifel retained its Buy rating and USD 13.00 target, as reported by Investing.com. On October 1, 2026, company president Patrick Fisher sold 150 shares at USD 9.44 per share, according to StockTitan. On October 8, 2026, Canaccord lowered its target from USD 18.00 to USD 13.00.
Next reporting date
Yahoo Finance lists November 3, 2026 as Orthofix Medical's next earnings date. The scheduled report gives the market a defined checkpoint for testing the lower target against operating performance.
Euro quote and market context
At Lang & Schwarz, the stock was trading at EUR 8.25 on October 8, 2026 at 1:43 p.m. CEST, up 0.61 percent versus the prior close of EUR 8.20. The primary Nasdaq quote from October 7, 2026 was USD 9.20 in after-hours trading, while the company had a market capitalization of USD 371.9 million and a 52-week range of USD 8.50 to USD 16.99.
The further course of trading is shown by the continuously updated real-time quote of Orthofix Medical stock.
Orthofix Medical stock facts
- Company: Orthofix Medical Inc.
- ISIN: US68752M1080
- Ticker: OFIX
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 8, 2026, 1:43 p.m. CEST: EUR 8.25
- Change versus prior close: plus 0.61 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 8.20
- Market capitalization: USD 371.9 million as of October 7, 2026
- 52-week range: USD 8.50-16.99 as of October 7, 2026
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report S&P 500.
